Cargando…
Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environme...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105681/ https://www.ncbi.nlm.nih.gov/pubmed/32265818 http://dx.doi.org/10.3389/fneur.2020.00163 |
_version_ | 1783512448769196032 |
---|---|
author | Bjerregaard, Victoria A. Schönewolf-Greulich, Bitten Juel Rasmussen, Lene Desler, Claus Tümer, Zeynep |
author_facet | Bjerregaard, Victoria A. Schönewolf-Greulich, Bitten Juel Rasmussen, Lene Desler, Claus Tümer, Zeynep |
author_sort | Bjerregaard, Victoria A. |
collection | PubMed |
description | Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environmental factors. The inner mitochondrial membrane peptidase, subunit 2 (IMMP2L) has been suggested as one of the susceptibility genes for GTS, and IMMP2L-deficient mouse and human cells show increased levels of mitochondrial oxidative stress and altered cell fate programming. Hence, a potential involvement of IMMP2L-induced mitochondrial dysfunction in GTS pathology is yet to be elucidated. To address this, we investigated mitochondrial function in a group of GTS patients with intragenic IMMP2L deletions and compared with GTS without IMMP2L deletions and healthy controls. Methods: Mitochondrial function in fibroblasts from GTS patients and non-GTS parents (with and without IMMP2L deletions) compared to healthy controls were evaluated by measuring mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial mass, and mitochondrial respiration. In addition, we evaluated apoptosis and senescence. Results: None of the mitochondrial parameters assessed in this study were significantly distinctive when comparing GTS patients with and without IMMP2L deletions against healthy controls or parents with or without IMMP2L deletions, and we did not observe altered cell programming. Conclusion: This study suggests that IMMP2L deletions do not lead to a substantial general mitochondrial dysfunction in GTS fibroblasts. Assessing a large cohort of controls and patients of similar age and gender would possibly reveal small differences in mitochondrial function. However, it is possible that IMMP2L variants affect mitochondrial function during specific instances of stress stimuli or in brain regions suggested to be affected in GTS. |
format | Online Article Text |
id | pubmed-7105681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71056812020-04-07 Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions Bjerregaard, Victoria A. Schönewolf-Greulich, Bitten Juel Rasmussen, Lene Desler, Claus Tümer, Zeynep Front Neurol Neurology Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environmental factors. The inner mitochondrial membrane peptidase, subunit 2 (IMMP2L) has been suggested as one of the susceptibility genes for GTS, and IMMP2L-deficient mouse and human cells show increased levels of mitochondrial oxidative stress and altered cell fate programming. Hence, a potential involvement of IMMP2L-induced mitochondrial dysfunction in GTS pathology is yet to be elucidated. To address this, we investigated mitochondrial function in a group of GTS patients with intragenic IMMP2L deletions and compared with GTS without IMMP2L deletions and healthy controls. Methods: Mitochondrial function in fibroblasts from GTS patients and non-GTS parents (with and without IMMP2L deletions) compared to healthy controls were evaluated by measuring mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial mass, and mitochondrial respiration. In addition, we evaluated apoptosis and senescence. Results: None of the mitochondrial parameters assessed in this study were significantly distinctive when comparing GTS patients with and without IMMP2L deletions against healthy controls or parents with or without IMMP2L deletions, and we did not observe altered cell programming. Conclusion: This study suggests that IMMP2L deletions do not lead to a substantial general mitochondrial dysfunction in GTS fibroblasts. Assessing a large cohort of controls and patients of similar age and gender would possibly reveal small differences in mitochondrial function. However, it is possible that IMMP2L variants affect mitochondrial function during specific instances of stress stimuli or in brain regions suggested to be affected in GTS. Frontiers Media S.A. 2020-03-24 /pmc/articles/PMC7105681/ /pubmed/32265818 http://dx.doi.org/10.3389/fneur.2020.00163 Text en Copyright © 2020 Bjerregaard, Schönewolf-Greulich, Juel Rasmussen, Desler and Tümer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Bjerregaard, Victoria A. Schönewolf-Greulich, Bitten Juel Rasmussen, Lene Desler, Claus Tümer, Zeynep Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title | Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title_full | Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title_fullStr | Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title_full_unstemmed | Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title_short | Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions |
title_sort | mitochondrial function in gilles de la tourette syndrome patients with and without intragenic immp2l deletions |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105681/ https://www.ncbi.nlm.nih.gov/pubmed/32265818 http://dx.doi.org/10.3389/fneur.2020.00163 |
work_keys_str_mv | AT bjerregaardvictoriaa mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions AT schonewolfgreulichbitten mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions AT juelrasmussenlene mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions AT deslerclaus mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions AT tumerzeynep mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions |